Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

China flag China · Delayed Price · Currency is CNY
4.260
-0.100 (-2.29%)
May 21, 2026, 3:00 PM CST
Market Cap2.96B +4.1%
Revenue (ttm)358.90M +1.7%
Net Income-171.66M
EPS-0.24
Shares Out694.63M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,315,062
Average Volume14,196,895
Open4.330
Previous Close4.360
Day's Range4.240 - 4.520
52-Week Range4.020 - 7.050
Beta0.26
RSI40.38
Earnings DateApr 25, 2026

About SHA:603669

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China. [Read more]

Sector Healthcare
Founded 2003
Employees 436
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603669
Full Company Profile

Financial Performance

In 2025, SHA:603669's revenue was 322.48 million, a decrease of -15.09% compared to the previous year's 379.78 million. Losses were -193.24 million, 47.8% more than in 2024.

Financial Statements